Staff Members - Benha University
Plasma Thymus & Activation-Regulated Chemokine (TARC) and Monocyte-Derived Chemokine (MDC) levels in Chronic Asthmatic Patients developed Acute Exacerbation
• 2011
Publication Information
Authors
Gamal Eliwa *, Samir A. Elsharkawy** and Ali Hasaneen**
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Objectives: The present study was designed to measure the plasma levels of Thymus and activation-regulated chemokine (TARC) and monocyte-derived chemokine (MDC) in chronic asthmatic patients required hospitalization for acute exacerbation.
Patients & Methods: The study included 40 patients; 29 males and 11 females with mean age 49.7±7 years. All patients had acute exacerbation of chronic bronchial asthma, and underwent clinical and radiological evaluation. Venous blood samples were obtained at time of admission (Day-0) and 4-weeks after inclusion in the study (Day-28) for ELISA estimation of plasma levels of TARC and MDC.
Results: Mean plasma levels of TARC estimated at time of admission (78.9±30.6; range: 43-175 pg/ml) were significantly higher (p
Patients & Methods: The study included 40 patients; 29 males and 11 females with mean age 49.7±7 years. All patients had acute exacerbation of chronic bronchial asthma, and underwent clinical and radiological evaluation. Venous blood samples were obtained at time of admission (Day-0) and 4-weeks after inclusion in the study (Day-28) for ELISA estimation of plasma levels of TARC and MDC.
Results: Mean plasma levels of TARC estimated at time of admission (78.9±30.6; range: 43-175 pg/ml) were significantly higher (p